#METABOLOMICS WORKBENCH mlhomme_20221213_043543 DATATRACK_ID:3642 STUDY_ID:ST002400 ANALYSIS_ID:AN003911 VERSION 1 CREATED_ON 12-16-2022 #PROJECT PR:PROJECT_TITLE Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis. PR:PROJECT_SUMMARY Background. Alcohol dehydrogenase (ADH1B), encoded by the ADH1B gene, is a PR:PROJECT_SUMMARY cytosolic enzyme mainly known for its role in ethanol catabolism in the liver. A PR:PROJECT_SUMMARY few studies have paved the way to show an equally important role of ADH1B in PR:PROJECT_SUMMARY adipocytes. This study aimed to better identify the cellular mechanisms and PR:PROJECT_SUMMARY signaling pathways involving ADH1B in adipose tissue and to determine if ADH1B PR:PROJECT_SUMMARY variants might contribute to adipose tissue dysfunction. Results. We showed that PR:PROJECT_SUMMARY CRISPR-Cas9-mediated ADH1B knockout (KO) in human adipose stem cells (ASC) PR:PROJECT_SUMMARY abolished adipocyte differentiation and decreased insulin response. This was PR:PROJECT_SUMMARY accompanied by oxidative stress, altered mitochondrial functions, and cellular PR:PROJECT_SUMMARY senescence. Lipidomic analysis revealed that ADH1B deficiency results in a major PR:PROJECT_SUMMARY remodeling of lipid composition in ASC. An ADH1B homozygous loss-of-function PR:PROJECT_SUMMARY variant was also identified in a patient presenting with a lipodystrophic and PR:PROJECT_SUMMARY insulin resistant syndrome associated with major liver dysfunction, leading to PR:PROJECT_SUMMARY early death. Discussion. This translational study underlines the crucial role of PR:PROJECT_SUMMARY ADH1B in adipose tissue. It unveils cellular mechanisms accounting for its key PR:PROJECT_SUMMARY role in adipogenesis, and adipocyte homeostasis. This study also identifies PR:PROJECT_SUMMARY ADH1B as a candidate gene in monogenic forms of lipodystrophic and insulin PR:PROJECT_SUMMARY resistant syndromes. PR:INSTITUTE INSERM PR:LAST_NAME Gautheron PR:FIRST_NAME Jérémie PR:ADDRESS 27 rue Chaligny, 75012 Paris France PR:EMAIL jeremie.gautheron@gmail.com PR:PHONE +33623398373 PR:DOI http://dx.doi.org/10.21228/M8VM64 #STUDY ST:STUDY_TITLE Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis ST:STUDY_SUMMARY Background. Alcohol dehydrogenase (ADH1B), encoded by the ADH1B gene, is a ST:STUDY_SUMMARY cytosolic enzyme mainly known for its role in ethanol catabolism in the liver. A ST:STUDY_SUMMARY few studies have paved the way to show an equally important role of ADH1B in ST:STUDY_SUMMARY adipocytes. This study aimed to better identify the cellular mechanisms and ST:STUDY_SUMMARY signaling pathways involving ADH1B in adipose tissue and to determine if ADH1B ST:STUDY_SUMMARY variants might contribute to adipose tissue dysfunction. Results. We showed that ST:STUDY_SUMMARY CRISPR-Cas9-mediated ADH1B knockout (KO) in human adipose stem cells (ASC) ST:STUDY_SUMMARY abolished adipocyte differentiation and decreased insulin response. This was ST:STUDY_SUMMARY accompanied by oxidative stress, altered mitochondrial functions, and cellular ST:STUDY_SUMMARY senescence. Lipidomic analysis revealed that ADH1B deficiency results in a major ST:STUDY_SUMMARY remodeling of lipid composition in ASC. An ADH1B homozygous loss-of-function ST:STUDY_SUMMARY variant was also identified in a patient presenting with a lipodystrophic and ST:STUDY_SUMMARY insulin resistant syndrome associated with major liver dysfunction, leading to ST:STUDY_SUMMARY early death. Discussion. This translational study underlines the crucial role of ST:STUDY_SUMMARY ADH1B in adipose tissue. It unveils cellular mechanisms accounting for its key ST:STUDY_SUMMARY role in adipogenesis, and adipocyte homeostasis. This study also identifies ST:STUDY_SUMMARY ADH1B as a candidate gene in monogenic forms of lipodystrophic and insulin ST:STUDY_SUMMARY resistant syndromes. ST:INSTITUTE INSERM ST:LAST_NAME Gautheron ST:FIRST_NAME Jérémie ST:ADDRESS 27 rue Chaligny ST:EMAIL jeremie.gautheron@gmail.com ST:PHONE +33623398373 ST:SUBMIT_DATE 2022-12-13 #SUBJECT SU:SUBJECT_TYPE Cultured cells SU:SUBJECT_SPECIES Homo sapiens #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS ADH1B_KO_01_LIP329 ADH1B_KO_01_LIP329 Genotype:ADH1B_KO Batch=1; RAW_FILE_NAME=LIP329_C18_1x_KO_01; RAW_FILE_NAME=LIP329_C18_10x_KO_01; RAW_FILE_NAME=LIP329_long_1x_KO_01; RAW_FILE_NAME=LIP329_short_1x_KO_01; RAW_FILE_NAME=LIP329_short_20x_KO_01 SUBJECT_SAMPLE_FACTORS ADH1B_KO_02_LIP329 ADH1B_KO_02_LIP329 Genotype:ADH1B_KO Batch=1; RAW_FILE_NAME=LIP329_C18_1x_KO_02; RAW_FILE_NAME=LIP329_C18_10x_KO_02; RAW_FILE_NAME=LIP329_long_1x_KO_02; RAW_FILE_NAME=LIP329_short_1x_KO_02; RAW_FILE_NAME=LIP329_short_20x_KO_02 SUBJECT_SAMPLE_FACTORS ADH1B_KO_03_LIP329 ADH1B_KO_03_LIP329 Genotype:ADH1B_KO Batch=1; RAW_FILE_NAME=LIP329_C18_1x_KO_03; RAW_FILE_NAME=LIP329_C18_10x_KO_03; RAW_FILE_NAME=LIP329_long_1x_KO_03; RAW_FILE_NAME=LIP329_short_1x_KO_03; RAW_FILE_NAME=LIP329_short_20x_KO_03 SUBJECT_SAMPLE_FACTORS ADH1B_KO_04_LIP329 ADH1B_KO_04_LIP329 Genotype:ADH1B_KO Batch=1; RAW_FILE_NAME=LIP329_C18_1x_KO_04; RAW_FILE_NAME=LIP329_C18_10x_KO_04; RAW_FILE_NAME=LIP329_long_1x_KO_04; RAW_FILE_NAME=LIP329_short_1x_KO_04; RAW_FILE_NAME=LIP329_short_20x_KO_04 SUBJECT_SAMPLE_FACTORS ADH1B_KO_05_LIP329 ADH1B_KO_05_LIP329 Genotype:ADH1B_KO Batch=1; RAW_FILE_NAME=LIP329_C18_1x_KO_05; RAW_FILE_NAME=LIP329_C18_10x_KO_05; RAW_FILE_NAME=LIP329_long_1x_KO_05; RAW_FILE_NAME=LIP329_short_1x_KO_05; RAW_FILE_NAME=LIP329_short_20x_KO_05 SUBJECT_SAMPLE_FACTORS CTL_01_LIP329 CTL_01_LIP329 Genotype:CTL Batch=1; RAW_FILE_NAME=LIP329_C18_1x_CTL_01; RAW_FILE_NAME=LIP329_C18_10x_CTL_01; RAW_FILE_NAME=LIP329_long_1x_CTL_01; RAW_FILE_NAME=LIP329_short_1x_CTL_01; RAW_FILE_NAME=LIP329_short_20x_CTL_01 SUBJECT_SAMPLE_FACTORS CTL_02_LIP329 CTL_02_LIP329 Genotype:CTL Batch=1; RAW_FILE_NAME=LIP329_C18_1x_CTL_02; RAW_FILE_NAME=LIP329_C18_10x_CTL_02; RAW_FILE_NAME=LIP329_long_1x_CTL_02; RAW_FILE_NAME=LIP329_short_1x_CTL_02; RAW_FILE_NAME=LIP329_short_20x_CTL_02 SUBJECT_SAMPLE_FACTORS CTL_03_LIP329 CTL_03_LIP329 Genotype:CTL Batch=1; RAW_FILE_NAME=LIP329_C18_1x_CTL_03; RAW_FILE_NAME=LIP329_C18_10x_CTL_03; RAW_FILE_NAME=LIP329_long_1x_CTL_03; RAW_FILE_NAME=LIP329_short_1x_CTL_03; RAW_FILE_NAME=LIP329_short_20x_CTL_03 SUBJECT_SAMPLE_FACTORS CTL_04_LIP329 CTL_04_LIP329 Genotype:CTL Batch=1; RAW_FILE_NAME=LIP329_C18_1x_CTL_04; RAW_FILE_NAME=LIP329_C18_10x_CTL_04; RAW_FILE_NAME=LIP329_long_1x_CTL_04; RAW_FILE_NAME=LIP329_short_1x_CTL_04; RAW_FILE_NAME=LIP329_short_20x_CTL_04 SUBJECT_SAMPLE_FACTORS CTL_05_LIP329 CTL_05_LIP329 Genotype:CTL Batch=1; RAW_FILE_NAME=LIP329_C18_1x_CTL_05; RAW_FILE_NAME=LIP329_C18_10x_CTL_05; RAW_FILE_NAME=LIP329_long_1x_CTL_05; RAW_FILE_NAME=LIP329_short_1x_CTL_05; RAW_FILE_NAME=LIP329_short_20x_CTL_05 #COLLECTION CO:COLLECTION_SUMMARY ASC were isolated from surgical samples of subcutaneous abdominal adipose tissue CO:COLLECTION_SUMMARY from a 25-year-old healthy woman with a normal body mass index (BMI). Adipose CO:COLLECTION_SUMMARY tissue was enzymatically digested with collagenase B (0.2%). CO:SAMPLE_TYPE Adipose tissue #TREATMENT TR:TREATMENT_SUMMARY After centrifugation, stromal vascular fraction was filtered, rinsed, plated and TR:TREATMENT_SUMMARY cultured in α-MEM with 10% Fetal Calf Serum (FCS), 1% GlutaMAX (#35050061, TR:TREATMENT_SUMMARY Thermo Fisher Scientific), 1% Penicillin/streptomycin (PS - 10,000 UI/mL), 1% TR:TREATMENT_SUMMARY HEPES and Fibroblast Growth Factor-2 (FGF-2 -145 nmol/L). After 24 h, only ASC TR:TREATMENT_SUMMARY adhered to plastic surfaces, while other cells were removed after culture medium TR:TREATMENT_SUMMARY replacement. ASC were maintained in an undifferentiated state in α-MEM TR:TREATMENT_SUMMARY supplemented with 10 % newborn calf serum (#CA-1151500; Biosera, MI, USA), 1% TR:TREATMENT_SUMMARY GlutaMAX, HEPES and P/S, and FGF-2 (145 nmol/L). Adipocyte differentiation was TR:TREATMENT_SUMMARY induced by treating 2-day post-confluent cultures with high-glucose (25 mmol/L) TR:TREATMENT_SUMMARY DMEM supplemented with 10 % FCS, 1 % PS, 1 µmol/L dexamethasone (#D4902; TR:TREATMENT_SUMMARY Sigma-Aldrich, MI, USA), 1 µM rosiglitazone (#D4902; Sigma-Aldrich), 250 µM TR:TREATMENT_SUMMARY 3-isobutyl-1-methyl xanthine (IBMX) (#I7018; Sigma-Aldrich) and 0.17 µmol/L TR:TREATMENT_SUMMARY insulin (#I0516; Sigma-Aldrich) for ten days. The medium was then replaced with TR:TREATMENT_SUMMARY high-glucose DMEM supplemented with 10% FCS, 1 % PS, 1 µmol/L rosiglitazone and TR:TREATMENT_SUMMARY 0.17 µM insulin, and changed to fresh medium every 2 days until the 20th day. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Lipid extraction. Lipids were extracted from ASC cells according to a modified SP:SAMPLEPREP_SUMMARY Folch method. Cell pellets were resuspended in 100µl methanol and supplemented SP:SAMPLEPREP_SUMMARY with deuterated internal standards. Lipids were extracted with 1.5 mL chloroform SP:SAMPLEPREP_SUMMARY and 650 µL methanol, sonicated for 15 min. Phase separation was triggered by SP:SAMPLEPREP_SUMMARY addition of 450 µL of ammonium carbonate (250 mM). Lower organic phase was SP:SAMPLEPREP_SUMMARY dried and resuspended in 200 µL of liquid chromatography – mass spectrometry SP:SAMPLEPREP_SUMMARY (LC-MS) solvent. #CHROMATOGRAPHY CH:INSTRUMENT_NAME Shimadzu 20AD CH:COLUMN_NAME Merck Supelco Ascentis Express C18 (150 x 2.1mm,2.7um) CH:COLUMN_TEMPERATURE 43 CH:FLOW_GRADIENT - CH:FLOW_RATE 300ul/min CH:SOLVENT_A 60% acetonitrile/40% water; 0.1% formic acid; 10mM ammonium formate CH:SOLVENT_B 10% acetonitrile/90% isopropanol; 0.1% formic acid; 10mM ammonium formate CH:CHROMATOGRAPHY_TYPE Reversed phase #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:INSTRUMENT_NAME ABI Sciex 4000 QTrap MS:INSTRUMENT_TYPE QTRAP MS:MS_TYPE ESI MS:MS_COMMENTS MRM acquisition of abundant neutral lipids: CE and TG after 10 fold dilution MS:MS_COMMENTS This acquisition is referred to as "C18_10x" MS:ION_MODE POSITIVE #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS mol% of total lipids MS_METABOLITE_DATA_START Samples ADH1B_KO_01_LIP329 ADH1B_KO_02_LIP329 ADH1B_KO_03_LIP329 ADH1B_KO_04_LIP329 ADH1B_KO_05_LIP329 CTL_01_LIP329 CTL_02_LIP329 CTL_03_LIP329 CTL_04_LIP329 CTL_05_LIP329 Factors Genotype:ADH1B_KO Genotype:ADH1B_KO Genotype:ADH1B_KO Genotype:ADH1B_KO Genotype:ADH1B_KO Genotype:CTL Genotype:CTL Genotype:CTL Genotype:CTL Genotype:CTL TG(48:0-16:0_32:0) 0.0221 0.0195 0.0211 0.0180 0.0185 0.0430 0.0297 0.0269 0.0188 0.0287 TG(48:1-16:1_32:0) 0.0064 0.0056 0.0066 0.0081 0.0073 0.0189 0.0127 0.0103 0.0077 0.0122 TG(48:1-18:1_30:0) 0.0040 0.0035 0.0043 0.0054 0.0048 0.0185 0.0117 0.0105 0.0078 0.0111 TG(48:2-14:1_34:1) 0.0002 0.0001 0.0002 0.0003 0.0002 0.0014 0.0009 0.0008 0.0005 0.0008 TG(48:2-16:0_32:2) 0.0017 0.0016 0.0019 0.0028 0.0026 0.0074 0.0046 0.0038 0.0028 0.0044 TG(48:2-18:1_30:1) 0.0009 0.0008 0.0010 0.0014 0.0014 0.0059 0.0036 0.0031 0.0024 0.0035 TG(48:2-18:2_30:0) 0.0007 0.0006 0.0008 0.0011 0.0009 0.0027 0.0016 0.0014 0.0009 0.0015 TG(48:3-14:0_34:3) 0.0002 0.0002 0.0002 0.0003 0.0003 0.0006 0.0004 0.0003 0.0002 0.0003 TG(48:3-16:1_32:2) 0.0006 0.0007 0.0008 0.0010 0.0009 0.0027 0.0017 0.0015 0.0011 0.0017 TG(49:1-14:0_35:1) 0.0006 0.0004 0.0005 0.0007 0.0007 0.0018 0.0011 0.0009 0.0007 0.0010 TG(49:1-15:0_34:1) 0.0019 0.0015 0.0018 0.0022 0.0019 0.0062 0.0038 0.0034 0.0026 0.0039 TG(49:1-17:0_32:1) 0.0010 0.0009 0.0011 0.0014 0.0011 0.0026 0.0018 0.0014 0.0011 0.0016 TG(50:0-18:0_32:0) 0.0130 0.0118 0.0131 0.0108 0.0107 0.0176 0.0115 0.0109 0.0075 0.0119 TG(50:1-14:0_36:1) 0.0020 0.0016 0.0019 0.0022 0.0020 0.0040 0.0027 0.0024 0.0017 0.0026 TG(50:1-18:1_32:0) 0.0371 0.0319 0.0375 0.0398 0.0363 0.0964 0.0678 0.0611 0.0456 0.0645 TG(50:2-18:0_32:2) 0.0010 0.0008 0.0011 0.0014 0.0013 0.0024 0.0015 0.0014 0.0010 0.0014 TG(50:2-18:1_32:1) 0.0207 0.0172 0.0213 0.0274 0.0262 0.0895 0.0598 0.0516 0.0398 0.0554 TG(50:2-18:2_32:0) 0.0069 0.0057 0.0071 0.0084 0.0072 0.0156 0.0100 0.0084 0.0056 0.0086 TG(50:3-14:1_36:2) 0.0001 0.0001 0.0001 0.0001 0.0002 0.0008 0.0005 0.0004 0.0003 0.0004 TG(50:3-18:1_32:2) 0.0021 0.0019 0.0023 0.0034 0.0032 0.0120 0.0075 0.0063 0.0048 0.0070 TG(50:3-18:2_32:1) 0.0034 0.0028 0.0037 0.0052 0.0049 0.0124 0.0077 0.0064 0.0045 0.0070 TG(50:4-14:0_36:4) 0.0003 0.0002 0.0003 0.0004 0.0004 0.0006 0.0004 0.0003 0.0002 0.0003 TG(50:4-18:2_32:2) 0.0004 0.0003 0.0004 0.0005 0.0005 0.0014 0.0008 0.0007 0.0005 0.0008 TG(51:0-18:0_33:0) 0.0013 0.0011 0.0012 0.0011 0.0010 0.0015 0.0009 0.0008 0.0005 0.0010 TG(51:1-18:1_33:0) 0.0059 0.0053 0.0058 0.0043 0.0053 0.0101 0.0073 0.0069 0.0050 0.0067 TG(51:2-15:0_36:2) 0.0013 0.0010 0.0013 0.0016 0.0013 0.0048 0.0030 0.0026 0.0019 0.0029 TG(51:2-16:0_35:2) 0.0061 0.0048 0.0061 0.0078 0.0070 0.0211 0.0131 0.0110 0.0085 0.0123 TG(51:2-16:1_35:1) 0.0025 0.0020 0.0025 0.0033 0.0030 0.0076 0.0047 0.0039 0.0031 0.0044 TG(52:1-18:1_34:0) 0.0355 0.0302 0.0338 0.0355 0.0313 0.0608 0.0403 0.0359 0.0259 0.0388 TG(52:2-16:0_36:2) 0.0517 0.0440 0.0509 0.0577 0.0553 0.1318 0.0935 0.0866 0.0637 0.0877 TG(52:3-16:1_36:2) 0.0129 0.0106 0.0130 0.0166 0.0160 0.0518 0.0341 0.0298 0.0223 0.0320 TG(52:3-18:2_34:1) 0.0197 0.0168 0.0199 0.0248 0.0239 0.0524 0.0349 0.0292 0.0219 0.0308 TG(52:4-16:0_36:4) 0.0046 0.0038 0.0045 0.0064 0.0049 0.0076 0.0053 0.0033 0.0029 0.0037 TG(52:4-16:1_36:3) 0.0051 0.0042 0.0051 0.0070 0.0072 0.0141 0.0091 0.0073 0.0052 0.0080 TG(52:4-20:4_32:0) 0.0094 0.0079 0.0095 0.0120 0.0117 0.0124 0.0078 0.0062 0.0048 0.0077 TG(52:5-20:4_32:1) 0.0038 0.0032 0.0041 0.0056 0.0055 0.0082 0.0049 0.0038 0.0030 0.0047 TG(53:2-17:0_36:2) 0.0041 0.0037 0.0039 0.0035 0.0042 0.0062 0.0041 0.0041 0.0030 0.0038 TG(54:1-18:1_36:0) 0.0070 0.0062 0.0067 0.0065 0.0055 0.0049 0.0029 0.0041 0.0018 0.0059 TG(54:2-18:0_36:2) 0.0319 0.0272 0.0303 0.0345 0.0306 0.0491 0.0320 0.0279 0.0204 0.0300 TG(54:2-20:2_34:0) 0.0016 0.0013 0.0016 0.0017 0.0014 0.0023 0.0015 0.0013 0.0010 0.0016 TG(54:3-18:1_36:2) 0.0694 0.0660 0.0684 0.0663 0.0777 0.1601 0.1218 0.1236 0.0860 0.1061 TG(54:3-20:3_34:0) 0.0001 0.0001 0.0001 0.0001 0.0001 0.0004 0.0002 0.0002 0.0002 0.0002 TG(54:4-18:0_36:4) 0.0025 0.0018 0.0021 0.0027 0.0025 0.0026 0.0020 0.0014 0.0010 0.0016 TG(54:4-18:2_36:2) 0.0112 0.0094 0.0109 0.0132 0.0136 0.0309 0.0194 0.0169 0.0125 0.0174 TG(54:4-20:4_34:0) 0.0080 0.0063 0.0077 0.0093 0.0083 0.0097 0.0060 0.0050 0.0038 0.0061 TG(54:5-18:1_36:4) 0.0041 0.0036 0.0039 0.0056 0.0053 0.0096 0.0062 0.0053 0.0036 0.0052 TG(54:5-20:4_34:1) 0.0171 0.0132 0.0172 0.0211 0.0213 0.0303 0.0192 0.0158 0.0118 0.0187 TG(54:5-22:5_32:0) 0.0067 0.0054 0.0066 0.0081 0.0076 0.0101 0.0065 0.0053 0.0042 0.0064 TG(54:6-18:2_36:4) 0.0006 0.0006 0.0006 0.0008 0.0009 0.0010 0.0006 0.0007 0.0004 0.0006 TG(54:6-18:3_36:3) 0.0003 0.0003 0.0003 0.0004 0.0004 0.0005 0.0004 0.0003 0.0002 0.0003 TG(54:6-20:4_34:2) 0.0039 0.0035 0.0045 0.0061 0.0060 0.0088 0.0048 0.0040 0.0031 0.0050 TG(54:6-22:6_32:0) 0.0056 0.0046 0.0057 0.0077 0.0070 0.0159 0.0101 0.0084 0.0065 0.0097 TG(56:6-20:4_36:2) 0.0117 0.0093 0.0119 0.0150 0.0142 0.0230 0.0144 0.0116 0.0092 0.0133 TG(56:6-20:5_36:1) 0.0019 0.0014 0.0019 0.0024 0.0022 0.0030 0.0019 0.0015 0.0012 0.0017 TG(56:6-22:5_34:1) 0.0151 0.0116 0.0148 0.0180 0.0184 0.0298 0.0198 0.0162 0.0129 0.0186 TG(56:6-22:6_34:0) 0.0048 0.0038 0.0047 0.0061 0.0051 0.0093 0.0059 0.0049 0.0040 0.0058 TG(56:8-20:4_36:4) 0.0015 0.0012 0.0016 0.0022 0.0021 0.0017 0.0009 0.0008 0.0006 0.0010 TG(58:8-22:6_36:2) 0.0085 0.0067 0.0084 0.0117 0.0109 0.0298 0.0201 0.0164 0.0129 0.0183 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name pubchem_id inchi_key kegg_id other_id other_id_type ri ri_type moverz_quant TG(48:0-16:0_32:0) 11.7 TG(48:1-16:1_32:0) 11.1 TG(48:1-18:1_30:0) 11 TG(48:2-14:1_34:1) 10.3 TG(48:2-16:0_32:2) 10.4 TG(48:2-18:1_30:1) 10.3 TG(48:2-18:2_30:0) 10.4 TG(48:3-14:0_34:3) 9.67 TG(48:3-16:1_32:2) 9.66 TG(49:1-14:0_35:1) 11.3 TG(49:1-15:0_34:1) 11.3 TG(49:1-17:0_32:1) 11.3 TG(50:0-18:0_32:0) 12.3 TG(50:1-14:0_36:1) 11.7 TG(50:1-18:1_32:0) 11.7 TG(50:2-18:0_32:2) 11.1 TG(50:2-18:1_32:1) 11 TG(50:2-18:2_32:0) 11.1 TG(50:3-14:1_36:2) 10.3 TG(50:3-18:1_32:2) 10.4 TG(50:3-18:2_32:1) 10.4 TG(50:4-14:0_36:4) 9.75 TG(50:4-18:2_32:2) 9.71 TG(51:0-18:0_33:0) 12.6 TG(51:1-18:1_33:0) 12 TG(51:2-15:0_36:2) 11.3 TG(51:2-16:0_35:2) 11.3 TG(51:2-16:1_35:1) 11.3 TG(52:1-18:1_34:0) 12.3 TG(52:2-16:0_36:2) 11.6 TG(52:3-16:1_36:2) 11 TG(52:3-18:2_34:1) 11.1 TG(52:4-16:0_36:4) 10.5 TG(52:4-16:1_36:3) 10.4 TG(52:4-20:4_32:0) 10.9 TG(52:5-20:4_32:1) 10.1 TG(53:2-17:0_36:2) 12 TG(54:1-18:1_36:0) 12.9 TG(54:2-18:0_36:2) 12.3 TG(54:2-20:2_34:0) 12.4 TG(54:3-18:1_36:2) 11.6 TG(54:3-20:3_34:0) 11.4 TG(54:4-18:0_36:4) 11.2 TG(54:4-18:2_36:2) 11.1 TG(54:4-20:4_34:0) 11.6 TG(54:5-18:1_36:4) 10.5 TG(54:5-20:4_34:1) 10.9 TG(54:5-22:5_32:0) 10.8 TG(54:6-18:2_36:4) 9.83 TG(54:6-18:3_36:3) 10 TG(54:6-20:4_34:2) 10.2 TG(54:6-22:6_32:0) 10.6 TG(56:6-20:4_36:2) 10.8 TG(56:6-20:5_36:1) 11 TG(56:6-22:5_34:1) 10.8 TG(56:6-22:6_34:0) 11.3 TG(56:8-20:4_36:4) 10 TG(58:8-22:6_36:2) 10.5 METABOLITES_END #END